Retinal gene therapy : methods and protocols /
Saved in:
| Imprint: | New York, NY : Humana Press : Springer, [2018] ©2018 |
|---|---|
| Description: | 1 online resource (xvi, 380 pages) : illustrations (some color) |
| Language: | English |
| Series: | Methods in molecular biology ; v. 1715 Methods in molecular biology (Clifton, N.J.) ; v. 1715. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11389354 |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | 11389354 | ||
| 005 | 20210625185243.2 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 171205t20182018nyua ob 001 0 eng d | ||
| 019 | |a 1013821057 | ||
| 020 | |a 9781493975228 |q (electronic bk.) | ||
| 020 | |a 1493975226 |q (electronic bk.) | ||
| 020 | |a 9781493975211 |q (print) | ||
| 020 | |a 1493975218 |q (print) | ||
| 035 | |a (OCoLC)1013933210 |z (OCoLC)1013821057 | ||
| 035 | 9 | |a (OCLCCM-CC)1013933210 | |
| 040 | |a RML |b eng |e pn |c RML |d RML |d YDX |d SCB |d GW5XE |d TFH |d STF |d OCLCO |d UAB |d OCLCO |d COO |d OCLCF |d OCLCO |d U3W |d OCLCO |d LVT |d TJC |d OCLCO |d CAUOI |d OCLCO |d OCLCQ |d OCLCA | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a RE551 | |
| 245 | 0 | 0 | |a Retinal gene therapy : |b methods and protocols / |c edited by Camiel J.F. Boon, Jan Wijnholds. |
| 264 | 1 | |a New York, NY : |b Humana Press : |b Springer, |c [2018] | |
| 264 | 4 | |c ©2018 | |
| 300 | |a 1 online resource (xvi, 380 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Methods in molecular biology ; |v v. 1715 | |
| 588 | 0 | |a Online resource; title from PDF title pate (SpringerProtocol, viewed December 5, 2017). | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t Small scale production of recombinant adeno-associated viral vectors for gene delivery to the nervous system / |r Joost Verhaagen, Barbara Hobo, Erich M.E. Ehlert, Ruben Eggers, Joanna A. Korecka, Stefan A. Hoyng, Callan L. Attwell, Alan R. Harvey, and Matthew R.J. Mason -- |t Small and micro-scale recombinant adeno-associated virus production and purification for ocular gene therapy applications / |r Christopher A. Reid and Daniel M. Lipinski -- |t Design and development of AAV-based gene supplementation therapies for achromatopsia and retinitis pigmentosa / |r Christian Schön, Elvir Becirovic, Martin Biel, and Stylianos Michalakis -- |t Development of multigenic lentiviral vectors for cell-specific expression of antiangiogenic miRNAs and protein factors / |r Anne Louise Askou and Thomas J. Corydon -- |t Design and in vitro use of antisense oligonucleotides to correct pre-mRNA splicing defects in inherited retinal dystrophies / |r Alejandro Garanto and Rob W.J. Collin -- |t Three-dimensional co-culture bioassay for screening of retinal gene delivery systems / |r Ding Wen Chen, Kathleen Pauloff, and Marianna Foldvari -- |t Retinal gene therapy for choroideremia : in vitro testing for gene augmentation using an adeno-associated viral (AAV) vector / |r Maria I. Patrício and Robert E. MacLaren -- |t In vivo electroporation of developing mouse retina / |r Jimmy de Melo and Seth Blackshaw -- |t Methods for in vivo CRISPR/Cas editing of the adult murine retina / |r Sandy S. Hung, Fan Li, Jiang-Hui Wang, Anna E. King, Bang V. Bui, Guei-Sheung Liu, and Alex W. Hewitt -- |t AAV gene augmentation therapy for CRB1-associated retinitis pigmentosa / |r C. Henrique Alves and Jan Wijnholds -- |t Dual AAV vectors for stargardt disease / |r Ivana Trapani-- |t Optogenetic retinal gene therapy with the light gated GPCR vertebrate rhodopsin / |r Benjamin M. Gaub, Michael H. Berry, Meike Visel, Amy Holt, Ehud Y. Isacoff, and John G. Flannery -- |t CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa : a brief methodology / |r Wen-Hsuan Wu, Yi-Ting Tsai, Sally Justus, Galaxy Y. Cho, Jesse D. Sengillo, Yu Xu, Thiago Cabral, Chyuan-Sheng Lin, Alexander G. Bassuk, Vinit B. Mahajan, and Stephen H. Tsang -- |t In-depth functional analysis of rodents by full-field electroretinography / |r Vithiyanjali Sothilingam, Regine Mühlfriedel, Naoyuki Tanimoto, and Mathias W. Seeliger -- |t Advanced ocular injection techniques for therapy approaches / |r Regine Mühlfriedel, Marina Garcia Garrido, Christine Wallrapp, and Mathias W. Seeliger -- |t Neutralizing antibodies against adeno-associated virus (AAV) : measurement and influence on retinal gene delivery / |r Mélissa Desrosiers and Deniz Dalkara -- |t Screening for neutralizing antibodies against natural and engineered AAV capsids in nonhuman primate retinas / |r Timothy P. Day, Leah C. Byrne, John G. Flannery, and David V. Schaffer -- |t Subretinal and intravitreal retinal injections in monkeys / |r Daniyar Dauletbekov, K. Ulrich Bartz-Schmidt, and M. Dominik Fischer -- |t Production of iPS-derived human retinal organoids for use in transgene expression assays / |r Peter M. Quinn, Thilo M. Buck, Charlotte Ohonin, Harald M.M. Mikkers, and Jan Wijnholds -- |t AAV serotype testing on cultured human donor retinal explants / |r Thilo M. Buck, Lucie P. Pellissier, Rogier M. Vos, Elon H.C. van Dijk, Camiel J.F. Boon, and Jan Wijnholds -- |t Human retinal explant culture for ex vivo validation of AAV gene therapy / |r Harry O. Orlans, Thomas L. Edwards, Samantha R. De Silva, Maria I. Patrício, and Robert E. MacLaren -- |t Visual acuity testing before and after intravitreal injection of rAAV2-ND4 in patients / |r Bin Li and Chenmian Wu -- |t Recording and analysis of the human clinical electroretinogram / |r Mathieu Gauvin, Allison L. Dorfman, and Pierre Lachapelle -- |t Recording and analysis of goldmann kinetic visual fields / |r Mays Talib, Gislin Dagnelie, and Camiel J.F. Boon -- |t Measuring central retinal sensitivity using microperimetry / |r Mays Talib, Jasleen K. Jolly, and Camiel J.F. Boon -- |t Inspection of the human retina by optical coherence tomography / |r Thomas Theelen and Michel M. Teussink -- |t Vector shedding and immunogenicity sampling for retinal gene therapy / |r Alun R. Barnard, Anna N. Rudenko, and Robert E. MacLaren. |
| 650 | 0 | |a Retina. |0 http://id.loc.gov/authorities/subjects/sh85113322 | |
| 650 | 0 | |a Gene therapy. |0 http://id.loc.gov/authorities/subjects/sh85053738 | |
| 650 | 0 | |a Genetic therapy | |
| 650 | 2 | |a Retina. | |
| 650 | 2 | |a Genetic Therapy |x methods. | |
| 650 | 7 | |a Gene therapy. |2 fast |0 (OCoLC)fst00939638 | |
| 650 | 7 | |a Retina. |2 fast |0 (OCoLC)fst01096191 | |
| 655 | 2 | |a Laboratory Manual. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Boon, Camiel J. F., |e editor. | |
| 700 | 1 | |a Wijnholds, Jan, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Retinal gene therapy . |d New York: Springer, 2018 |z 9781493975211 |
| 830 | 0 | |a Methods in molecular biology (Clifton, N.J.) ; |v v. 1715. |x 1064-3745 |0 http://id.loc.gov/authorities/names/n92002874 | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i 4d9e825b-5b26-5219-ac2d-7264a0d407e0 |s 8fe93a72-be4f-5e41-bf36-f2635771db52 |
| 928 | |t Library of Congress classification |a RE551 |l Online |c UC-FullText |u https://link.springer.com/10.1007/978-1-4939-7522-8 |z Springer Nature |g ebooks |i 12550794 | ||